FDA.reportPublic FDA data

POLOXAMER 188

Substance profile for UNII LQA7B6G8JG, enriched with FDA NDC listings, DailyMed labels, legacy aliases, and open chemistry identifiers.

Substance Identity#

UNII
LQA7B6G8JG
Preferred term
POLOXAMER 188
Registry number
691397-13-4
Ingredient type
INGREDIENT SUBSTANCE
Molecular formula
Polymer substance not supported

Chemical And Database Identifiers#

RxCUI
155152
PubChem
0
NCIt
C80936
INN ID
0

Open Chemistry Sources#

Source, Identifier, Link table
SourceIdentifierLink
RxNorm155152mor.nlm.nih.gov/RxNav/search?searchBy=RXCUI&searchTerm=155152
NCI ThesaurusC80936ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&code=C80936
FDA Substance Registration SystemLQA7B6G8JGprecision.fda.gov/uniisearch/srs/unii/LQA7B6G8JG

DailyMed Socrata Ingredients#

Type, DailyMed label, SPL version table
TypeDailyMed labelSPL version
INACTIVE INGREDIENTGLIMEPIRIDE1
INACTIVE INGREDIENTThese highlights do not include all the information needed to use atovaquone and proguanil hydrochloride tablets safely and effectively. See full prescribing information for atovaquone and proguanil hydrochloride tablets . ATOVAQUONE AND PROGUANIL HYDROCHLORIDE TABLETS, for oral administration Initial U.S. Approval: 20001
INACTIVE INGREDIENTIRBESARTAN TABLETS USP 7464 7465 75141002
INACTIVE INGREDIENTLovastatin Tablet USP1
INACTIVE INGREDIENTLovastatin Tablet USP2
INACTIVE INGREDIENTThese highlights do not include all the information needed to use metoprolol succinate extended-release tablets USP safely and effectively. See full prescribing information for metoprolol succinate extended release tablets USP. Metoprolol succinate extended-release tablets USP Initial U.S. Approval: 19921
INACTIVE INGREDIENTSuperValu Inc. Antibiotic Cream + Pain Relief Drug Facts2
INACTIVE INGREDIENTLovastatin Tablet USP1
INACTIVE INGREDIENTThese highlights do not include all the information needed to use DUAVEE safely and effectively. See full prescribing information for DUAVEE. DUAVEE ® (conjugated estrogens/bazedoxifene) tablets for oral use Initial U.S. approval: 20131
INACTIVE INGREDIENTAtovaquone and Proguanil Hydrochloride Tablets1
INACTIVE INGREDIENTSepticare™1
INACTIVE INGREDIENTPerifoam™1
INACTIVE INGREDIENTAtovaquone and Proguanil Hydrochloride Tablets1
INACTIVE INGREDIENTBenazepril Hydrochloride and Hydrochlorothiazide Tablets2
INACTIVE INGREDIENTThese highlights do not include all the information needed to use irbesartan and hydrochlorothiazide tablets USP safely and effectively. See full prescribing information for irbesartan and hydrochlorothiazide tablets USP. IRBESARTAN and HYDROCHLOROTHIAZIDE tablets USP for oral use Initial U.S. Approval: 19974
INACTIVE INGREDIENTThese highlights do not include all the information needed to use metoprolol succinate extended-release tablets USP safely and effectively. See full prescribing information for metoprolol succinate extended release tablets USP. Metoprolol succinate extended-release tablets USP Initial U.S. Approval: 19923
INACTIVE INGREDIENTAtovaquone and Proguanil Hydrochloride Tablets1
INACTIVE INGREDIENTDrug Facts1
INACTIVE INGREDIENTDrug Facts1
INACTIVE INGREDIENTAtovaquone and Proguanil Hydrochloride Tablets1
INACTIVE INGREDIENTLovastatin Tablet USP1
INACTIVE INGREDIENTLovastatin Tablet USP1
INACTIVE INGREDIENTNeomycin and Polymyxin B Sulfates and Gramicidin Ophthalmic Solution USP (Sterile)3
INACTIVE INGREDIENTThese highlights do not include all the information needed to use metoprolol succinate extended-release tablets USP safely and effectively. See full prescribing information for metoprolol succinate extended release tablets USP. Metoprolol succinate extended-release tablets USP Initial U.S. Approval: 19921
INACTIVE INGREDIENTThese highlights do not include all the information needed to use metoprolol succinate extended-release tablets USP safely and effectively. See full prescribing information for metoprolol succinate extended release tablets USP. Metoprolol succinate extended-release tablets USP for Oral Use Initial U.S. Approval: 19923
INACTIVE INGREDIENTThese highlights do not include all the information needed to use Fenoglide ® safely and effectively. See full prescribing information for Fenoglide. Fenoglide (fenofibrate) Tablets Initial U.S. Approval: 19932
INACTIVE INGREDIENTNeomycin and Polymyxin B Sulfates and Gramicidin Ophthalmic Solution USP (Sterile)1
INACTIVE INGREDIENTNeomycin and Polymyxin B Sulfates and Gramicidin Ophthalmic Solution USP1
INACTIVE INGREDIENTdrug facts2
INACTIVE INGREDIENTdrug facts1
INACTIVE INGREDIENTBenazepril Hydrochloride and Hydrochlorothiazide Tablets3
INACTIVE INGREDIENTThese highlights do not include all the information needed to use FENOGLIDE safely and effectively. See full prescribing information for FENOGLIDE. FENOGLIDE (fenofibrate) tablet for oral use Initial U.S. Approval: 19931
INACTIVE INGREDIENTThese highlights do not include all the information needed to use Norditropin Cartridges safely and effectively. See full prescribing information for Norditropin Cartridges. Norditropin ® Cartridges [somatropin (rDNA origin) injection], for subcutaneous use Initial U.S. Approval: 19871
INACTIVE INGREDIENTAVAPRO (IRBESARTAN) TABLET [LAKE ERIE MEDICAL & SURGICAL SUPPLY DBA QUALITY CARE PRODUCTS LLC]3698
ACTIVE MOIETYKANG DU QING (POLOXAMER 188) GEL [SHENZHEN SENTON SCIENCE & TECHNOLOGY CO. LTD]3061
ACTIVE INGREDIENTKANG DU QING (POLOXAMER 188) GEL [SHENZHEN SENTON SCIENCE & TECHNOLOGY CO. LTD]3061
INACTIVE INGREDIENTAVAPRO (IRBESARTAN) TABLET [BRYANT RANCH PREPACK]1001
INACTIVE INGREDIENTATOVAQUONE AND PROGUANIL HCL (ATOVAQUONE AND PROGUANIL HYDROCHLORIDE) TABLET, FILM COATED [BRYANT RANCH PREPACK]1000
INACTIVE INGREDIENTAVAPRO (IRBESARTAN) TABLET [BRYANT RANCH PREPACK]1000
INACTIVE INGREDIENTBENAZEPRIL HYDROCHLORIDE AND HYDROCHLOROTHIAZIDE TABLET, FILM COATED [BRYANT RANCH PREPACK]1000
INACTIVE INGREDIENTLOVASTATIN TABLET [BRYANT RANCH PREPACK]1000
INACTIVE INGREDIENTRAPAMUNE (SIROLIMUS) SOLUTION RAPAMUNE (SIROLIMUS) TABLET, SUGAR COATED [WYETH PHARMACEUTICALS INC., A SUBSIDIARY OF PFIZER INC.]47
INACTIVE INGREDIENTBANZEL (RUFINAMIDE) TABLET, FILM COATED BANZEL (RUFINAMIDE) SUSPENSION [EISAI INC.]24
INACTIVE INGREDIENTOMNITROPE (SOMATROPIN) INJECTION, SOLUTION OMNITROPE (SOMATROPIN) KIT [SANDOZ INC]24
INACTIVE INGREDIENTBENAZEPRIL HYDROCHLORIDE AND HYDROCHLOROTHIAZIDE TABLET, FILM COATED [EON LABS, INC.]22
INACTIVE INGREDIENTTASIGNA (NILOTINIB) CAPSULE [NOVARTIS PHARMACEUTICALS CORPORATION]19
INACTIVE INGREDIENTMALARONE (ATOVAQUONE AND PROGUANIL HYDROCHLORIDE) TABLET, FILM COATED [GLAXOSMITHKLINE LLC]16
INACTIVE INGREDIENTMETOPROLOL SUCCINATE TABLET, FILM COATED, EXTENDED RELEASE [ACTAVIS PHARMA, INC.]15
INACTIVE INGREDIENTNORDITROPIN (SOMATROPIN) INJECTION, SOLUTION [NOVO NORDISK]15
INACTIVE INGREDIENTORENCIA (ABATACEPT) INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION ORENCIA (ABATACEPT) INJECTION, SOLUTION [E.R. SQUIBB & SONS, L.L.C.]15
INACTIVE INGREDIENTANTIBIOTIC AND PAIN RELIEF MAXIMUM STRENGTH (NEOMYCIN SULFATE, POLYMYXIN B SULFATE, PRAMOXINE HYDROCHLORIDE) CREAM [CVS PHARMACY]14
INACTIVE INGREDIENTQUILLIVANT XR (METHYLPHENIDATE HYDROCHLORIDE) POWDER, FOR SUSPENSION [NEXTWAVE PHARMACEUTICALS, INC.]13
INACTIVE INGREDIENTMALARONE (ATOVAQUONE AND PROGUANIL HYDROCHLORIDE) TABLET, FILM COATED [PD-RX PHARMACEUTICALS, INC.]12
INACTIVE INGREDIENTSANDOSTATIN LAR DEPOT (OCTREOTIDE ACETATE) KIT SANDOSTATIN LAR DEPOT DEMONSTRATION KIT (OCTREOTIDE ACETATE) KIT [NOVARTIS PHARMACEUTICALS CORPORATION]12
INACTIVE INGREDIENTBENAZEPRIL HYDROCHLORIDE AND HYDROCHLOROTHIAZIDE TABLET, FILM COATED [UPSHER-SMITH LABORATORIES, INC.]11
INACTIVE INGREDIENTMEPRON (ATOVAQUONE) SUSPENSION [GLAXOSMITHKLINE LLC]11
INACTIVE INGREDIENTELITEK (RASBURICASE) KIT [SANOFI-AVENTIS U.S. LLC]10
INACTIVE INGREDIENTATOVAQUONE SUSPENSION [AMNEAL PHARMACEUTICALS OF NEW YORK, LLC]9
INACTIVE INGREDIENTAVAPRO (IRBESARTAN) TABLET [BRISTOL-MYERS SQUIBB COMPANY]9
INACTIVE INGREDIENTCLARITHROMYCIN FOR SUSPENSION [SANDOZ INC]9
INACTIVE INGREDIENTCLEOCIN PEDIATRIC (CLINDAMYCIN PALMITATE HYDROCHLORIDE) GRANULE, FOR SOLUTION [PHARMACIA AND UPJOHN COMPANY]9
INACTIVE INGREDIENTBOSULIF (BOSUTINIB MONOHYDRATE) TABLET, FILM COATED [PFIZER LABORATORIES DIV PFIZER INC]8
INACTIVE INGREDIENTFENOGLIDE (FENOFIBRATE) TABLET [SANTARUS, INC.]8
INACTIVE INGREDIENTGLIMEPIRIDE TABLET [QUALITEST PHARMACEUTICALS]8
INACTIVE INGREDIENTLOVASTATIN TABLET [PD-RX PHARMACEUTICALS, INC.]8
INACTIVE INGREDIENTSIROLIMUS TABLET, SUGAR COATED [GREENSTONE LLC]8
INACTIVE INGREDIENTATOVAQUONE AND PROGUANIL HYDROCHLORIDE TABLET, FILM COATED ATOVAQUONE AND PROGUANIL HYDROCHLORIDE PEDIATRIC TABLET, FILM COATED [GLENMARK PHARMACEUTICALS INC.,USA]7
INACTIVE INGREDIENTDUAVEE (CONJUGATED ESTROGENS/BAZEDOXIFENE) TABLET, FILM COATED [WYETH PHARMACEUTICALS INC., A SUBSIDIARY OF PFIZER INC.]7
INACTIVE INGREDIENTGAZYVA (OBINUTUZUMAB) INJECTION, SOLUTION, CONCENTRATE [GENENTECH, INC.]7
INACTIVE INGREDIENTGLIMEPIRIDE TABLET [CARLSBAD TECHNOLOGY, INC.]7
INACTIVE INGREDIENTLOVASTATIN TABLET [CARLSBAD TECHNOLOGY, INC.]7
INACTIVE INGREDIENTNEOMYCIN AND POLYMYXIN B SULFATES AND GRAMICIDIN (NEOMYCIN SULFATE, POLYMYXIN B SULFATE AND GRAMICIDIN) SOLUTION/ DROPS [BAUSCH & LOMB INCORPORATED]7
INACTIVE INGREDIENTPRANDIMET (REPAGLINIDE AND METFORMIN HYDROCHLORIDE) TABLET [NOVO NORDISK]7
INACTIVE INGREDIENTPREDNISONE TABLET PREDNISONE SOLUTION PREDNISONE INTENSOL SOLUTION, CONCENTRATE [ROXANE LABORATORIES, INC.]7
INACTIVE INGREDIENTSIROLIMUS TABLET [DR. REDDY'S LABORATORIES LIMITED]7
INACTIVE INGREDIENTATOVAQUONE AND PROGUANIL HCL (ATOVAQUONE AND PROGUANIL HYDROCHLORIDE) TABLET, FILM COATED [PD-RX PHARMACEUTICALS, INC.]6
INACTIVE INGREDIENTATOVAQUONE AND PROGUANIL HYDROCHLORIDE PEDIATRIC (ATOVAQUONE AND PROGUANIL HYDROCHLORIDE) TABLET, FILM COATED [GLENMARK GENERICS INC]6
INACTIVE INGREDIENTFLO-PRED (PREDNISOLONE ACETATE) SUSPENSION [TARO PHARMACEUTICALS U.S.A., INC.]6
INACTIVE INGREDIENTIRBESARTAN AND HYDROCHLOROTHIAZIDE TABLET, FILM COATED [LUPIN PHARMACEUTICALS, INC.]6
INACTIVE INGREDIENTIRBESARTAN AND HYDROCHLOROTHIAZIDE TABLET, FILM COATED [WATSON LABORATORIES, INC.]6
INACTIVE INGREDIENTORAQIX (LIDOCAINE AND PRILOCAINE) GEL [DENTSPLY PHARMACEUTICAL]6
INACTIVE INGREDIENTANTISEPTIC (CETYLPYRIDINIUM CHLORIDE) MOUTHWASH [TARGET CORPORATION]5
INACTIVE INGREDIENTATOVAQUONE AND PROGUANIL HYDROCHLORIDE TABLET, FILM COATED [PD-RX PHARMACEUTICALS, INC.]5
INACTIVE INGREDIENTCARBAMAZEPINE TABLET, CHEWABLE CARBAMAZEPINE TABLET CARBAMAZEPINE TABLET, EXTENDED RELEASE CARBAMAZEPINE SUSPENSION [TARO PHARMACEUTICALS U.S.A., INC.]5
INACTIVE INGREDIENTCLINDAMYCIN PALMITATE HYDROCHLORIDE (PEDIATRIC) (CLINDAMYCIN PALMITATE HYDROCHLORIDE) GRANULE, FOR SOLUTION [LYNE LABORATORIES, INC.]5
INACTIVE INGREDIENTCLINDAMYCIN PALMITATE HYDROCHLORIDE POWDER, FOR SOLUTION [AMNEAL PHARMACEUTICALS OF NEW YORK, LLC]5
INACTIVE INGREDIENTCLINDAMYCIN PALMITATE HYDROCHLORIDE SOLUTION [GREENSTONE LLC]5
INACTIVE INGREDIENTGONAL-F RFF PEN (FOLLTROPIN ALFA) INJECTION, SOLUTION [EMD SERONO, INC.]5
INACTIVE INGREDIENTIRBESARTAN TABLET [LEGACY PHARMACEUTICAL PACKAGING]5
INACTIVE INGREDIENTMEFLOQUINE HYDROCHLORIDE TABLET [BARR LABORATORIES INC.]5
INACTIVE INGREDIENTPROGLYCEM (DIAZOXIDE) SUSPENSION [TEVA BRANDED PHARMACEUTICAL PRODUCTS R&D, INC.]5
INACTIVE INGREDIENTSIROLIMUS TABLET, FILM COATED [ZYDUS PHARMACEUTICALS (USA) INC.]5
INACTIVE INGREDIENTVALSARTAN TABLET [QUALITEST PHARMACEUTICALS]5
INACTIVE INGREDIENTATOVAQUONE AND PROGUANIL HCL (ATOVAQUONE AND PROGUANIL HYDROCHLORIDE) TABLET, FILM COATED [PRASCO LABORATORIES]4
INACTIVE INGREDIENTBIOTENE (SODIUM MONOFLUOROPHOSPHATE) PASTE BIOTENE FRESH MINT ORIGINAL (SODIUM MONOFLUOROPHOSPHATE) PASTE BIOTENE GENTLE MINT (SODIUM MONOFLUOROPHOSPHATE) GEL [GLAXOSMITHKLINE CONSUMER HEALTHCARE LP]4
INACTIVE INGREDIENTCLINDAMYCIN PALMITATE HYDROCHLORIDE GRANULE, FOR SOLUTION [PADDOCK LABORATORIES, LLC]4
INACTIVE INGREDIENTGRISEOFULVIN TABLET [RISING PHARMACEUTICALS, INC]4
INACTIVE INGREDIENTHEALTH (CETYLPYRIDINIUM CHLORIDE) MOUTHWASH [DOLGENCORP, LLC]4
INACTIVE INGREDIENTIRBESARTAN AND HYDROCHLOROTHIAZIDE TABLET, FILM COATED [TEVA PHARMACEUTICALS USA INC]4
INACTIVE INGREDIENTIRBESARTAN TABLET [TEVA PHARMACEUTICALS USA INC]4
INACTIVE INGREDIENTJADENU (DEFERASIROX) TABLET, FILM COATED [NOVARTIS PHARMACEUTICALS CORPORATION]4
INACTIVE INGREDIENTLOVASTATIN (LOVASTATIN) TABLET [AVKARE, INC.]4
INACTIVE INGREDIENTLOVASTATIN (LOVASTATIN) TABLET [AVPAK]4
INACTIVE INGREDIENTMIRCERA (METHOXY POLYETHYLENE GLYCOL-EPOETIN BETA) INJECTION, SOLUTION [GENENTECH, INC.]4
INACTIVE INGREDIENTOVIDREL (CHORIOGONADOTROPIN ALFA) INJECTION, SOLUTION [EMD SERONO, INC.]4
INACTIVE INGREDIENTXERESE (ACYCLOVIR AND HYDROCORTISONE) CREAM [VALEANT PHARMACEUTICALS NORTH AMERICA LLC]4
INACTIVE INGREDIENTANTIBIOTIC PLUS PAIN RELIEF (NEOMYCIN, POLYMYXIN B SULFATE, AND PRAMOXINE HYDROCHLORIDE) CREAM [KROGER COMPANY]3
INACTIVE INGREDIENTANTISEPTIC (CETYLPYRIDINIUM CHLORIDE) RINSE [VALU MERCHANDISERS.CO]3
INACTIVE INGREDIENTANTISEPTIC (CETYLPYRIDINIUM CHLORIDE) RINSE [YOUR MILITARY EXCHANGES]3
INACTIVE INGREDIENTATOVAQUONE AND PROGUANIL HYDROCHLORIDE TABLET, FILM COATED [BLUEPOINT LABORATORIES]3
INACTIVE INGREDIENTATOVAQUONE SUSPENSION [PRASCO LABORATORIES]3
INACTIVE INGREDIENTBENAZEPRIL HYDROCHLORIDE AND HYDROCHLOROTHIAZIDE TABLET, FILM COATED [BRYANT RANCH PREPACK]3
INACTIVE INGREDIENTCLINDAMYCIN PALMITATE HYDROCHLORIDE (PEDIATRIC) SOLUTION [AUROBINDO PHARMA LIMITED]3
INACTIVE INGREDIENTDG HEALTH ANTIBIOTIC (NEOMYCIN, POLYMYXIN B, PRAMOXINE HCL) CREAM [DOLGENCORP INC]3
INACTIVE INGREDIENTENVARSUS XR (TACROLIMUS) TABLET, EXTENDED RELEASE [VELOXIS PHARMACEUTICALS, INC]3
INACTIVE INGREDIENTGONAL-F RFF REDI-JECT (FOLLITROPIN) INJECTION, SOLUTION [EMD SERONO, INC.]3
INACTIVE INGREDIENTLOVASTATIN TABLET [GOLDEN STATE MEDICAL SUPPLY, INC.]3
INACTIVE INGREDIENTLOVASTATIN TABLET [ST MARYS MEDICAL PARK PHARMACY]3
INACTIVE INGREDIENTMETHADONE HYDROCHLORIDE CONCENTRATE [VISTAPHARM INC]3
INACTIVE INGREDIENTMETOPROLOL SUCCINATE TABLET, EXTENDED RELEASE [GOLDEN STATE MEDICAL SUPPLY, INC.]3

Inactive Ingredient Database#

Browse recovered IID releases and source provenance.

Current IID rows for UNII LQA7B6G8JG page 1 of 1 · 22 matching rows.

Ingredient, UNII, CAS table
IngredientUNIICASDosage formRoutePotencyMaximum daily exposure
POLOXAMER 188LQA7B6G8JG691397134INJECTION, POWDER, FOR SUSPENSIONINTRAMUSCULAR4 mg
POLOXAMER 188LQA7B6G8JG691397134POWDER, FOR SUSPENSIONINTRAMUSCULAR0.2 %w/v
POLOXAMER 188LQA7B6G8JG691397134INJECTIONINTRAVENOUS6 mg
POLOXAMER 188LQA7B6G8JG691397134INJECTION, POWDER, FOR SOLUTIONINTRAVENOUS2.2 mg
POLOXAMER 188LQA7B6G8JG691397134SOLUTIONOPHTHALMIC0.1 %w/v
POLOXAMER 188LQA7B6G8JG691397134CAPSULEORAL151 mg
POLOXAMER 188LQA7B6G8JG691397134CAPSULE, DELAYED RELEASEORAL18 mg
POLOXAMER 188LQA7B6G8JG691397134CONCENTRATEORAL3 mg
POLOXAMER 188LQA7B6G8JG691397134GRANULEORAL81 mg
POLOXAMER 188LQA7B6G8JG691397134GRANULE, FOR SOLUTIONORAL624 mg
POLOXAMER 188LQA7B6G8JG691397134POWDER, FOR SOLUTIONORAL500 mg
POLOXAMER 188LQA7B6G8JG691397134POWDER, FOR SUSPENSIONORAL30 mg
POLOXAMER 188LQA7B6G8JG691397134SOLUTIONORAL1800 mg
POLOXAMER 188LQA7B6G8JG691397134SUSPENSIONORAL1600 mg
POLOXAMER 188LQA7B6G8JG691397134SUSPENSION, EXTENDED RELEASEORAL6 mg
POLOXAMER 188LQA7B6G8JG691397134TABLETORAL100 mg
POLOXAMER 188LQA7B6G8JG691397134TABLET, COATEDORAL3 mg
POLOXAMER 188LQA7B6G8JG691397134TABLET, DELAYED RELEASEORAL6 mg
POLOXAMER 188LQA7B6G8JG691397134TABLET, EXTENDED RELEASEORAL37 mg
POLOXAMER 188LQA7B6G8JG691397134TABLET, FILM COATEDORAL3 mg
POLOXAMER 188LQA7B6G8JG691397134GELPERIODONTAL55 mg
POLOXAMER 188LQA7B6G8JG691397134CREAMTOPICAL1 %w/w